Literature DB >> 19480919

Chapter 8. Activation mechanisms of chemokine receptors.

Pia C Jensen1, Mette M Rosenkilde.   

Abstract

Chemokine receptors belong to the large family of 7-transmembrane (7TM) G-protein-coupled receptors. These receptors are targeted and activated by a variety of different ligands, indicating that activation is a result of similar molecular mechanisms but not necessarily similar modes of ligand binding. Attempts to unravel the activation mechanism of 7TM receptors have led to the conclusion that activation involves movements of the transmembrane segments VI and VII in particular, as recently gathered in the Global Toggle Switch Model. However, to understand the activation mechanism completely, more research has to be done in this field. Chemokine receptors are interesting tools in this matter. First, the chemokine system has a high degree of promiscuity that allows several chemokines to target one receptor in different ways, as well as a single chemokine ligand to target several receptors in different ways. Second, the endogenous ligands are large proteins that mainly activate their cognate receptors by interacting with various extracellular-located receptor regions. It is, however, also possible to introduce agonism of simple ligands like metal ions. Thus, the chemokine system offers the possibility to test and compare the activation profiles of several chemically diverse ligands. This also brings up the interesting discussion of allosterism, because small molecules in the chemokine field often interact with allosteric receptor sites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19480919     DOI: 10.1016/S0076-6879(09)05408-1

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  5 in total

1.  Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.

Authors:  P C Rummel; K N Arfelt; L Baumann; T J Jenkins; S Thiele; H R Lüttichau; A Johnsen; J Pease; S Ghosh; R Kolbeck; M M Rosenkilde
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

2.  Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach.

Authors:  Stefanie Thiele; Anne Steen; Pia C Jensen; Jacek Mokrosinski; Thomas M Frimurer; Mette M Rosenkilde
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

3.  Ligand modulation of the Epstein-Barr virus-induced seven-transmembrane receptor EBI2: identification of a potent and efficacious inverse agonist.

Authors:  Tau Benned-Jensen; Christopher Smethurst; Peter J Holst; Kevin R Page; Howard Sauls; Bjørn Sivertsen; Thue W Schwartz; Andy Blanchard; Robert Jepras; Mette M Rosenkilde
Journal:  J Biol Chem       Date:  2011-06-14       Impact factor: 5.157

4.  Reversed binding of a small molecule ligand in homologous chemokine receptors - differential role of extracellular loop 2.

Authors:  P C Jensen; S Thiele; A Steen; A Elder; R Kolbeck; S Ghosh; T M Frimurer; M M Rosenkilde
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 5.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.